Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Garbe

Showing results (301-310 of 501) with videos related to

Pageof 51
Sort By:
The American Journal of Pathology|July 18, 2020
Expression of DNA Methyltransferase 1 Is a Hallmark of Melanoma, Correlating with Proliferation and Response to B-Raf and Mitogen-Activated Protein Kinase Inhibition in Melanocytic TumorsMaximilian Gassenmaier, Maximilian Rentschler, Birgit Fehrenbacher, et al.
Cancer Immunology Research|June 8, 2014
Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responsesBenjamin Weide, Thomas K Eigentler, Annette Pflugfelder, et al.
Ebiomedicine|July 19, 2016
A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to VemurafenibTobias Sinnberg, Elena Makino, Marcel A Krueger, et al.
Immunotherapy|January 5, 2019
Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasisTeresa Amaral, Ioanna Tampouri, Thomas Eigentler, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2024
Isolated melanoma cells in sentinel lymph node in stage IIIA melanoma correlate with a favorable prognosis similar to stage IBTeresa Amaral, Lena Nanz, Rudolf Stadler, et al.
Journal of Cancer Research and Clinical Oncology|February 22, 2022
TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapyJulia Eckardt, Christopher Schroeder, Peter Martus, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 21, 2018
6- and 8-Prenylnaringenin, Novel Natural Histone Deacetylase Inhibitors Found in Hops, Exert Antitumor Activity on Melanoma CellsSascha Venturelli, Heike Niessner, Tobias Sinnberg, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2021
Neoadjuvant and adjuvant end-points in health technology assessment in oncologyNadia Harbeck, Andreas Schneeweiss, Peter Thuss-Patience, et al.
Journal of Innate Immunity|January 25, 2014
Processing of laminin α chains generates peptides involved in wound healing and host defenseIlknur Senyürek, Wolfgang E Kempf, Gerd Klein, et al.
Plos One|August 17, 2019
Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockadeJonas Bochem, Henning Zelba, Teresa Amaral, et al.
Pageof 51

Showing results (301-310 of 501) with videos related to

Sort By:
Pageof 51
The American Journal of Pathology|July 18, 2020
Expression of DNA Methyltransferase 1 Is a Hallmark of Melanoma, Correlating with Proliferation and Response to B-Raf and Mitogen-Activated Protein Kinase Inhibition in Melanocytic TumorsMaximilian Gassenmaier, Maximilian Rentschler, Birgit Fehrenbacher, et al.
Cancer Immunology Research|June 8, 2014
Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responsesBenjamin Weide, Thomas K Eigentler, Annette Pflugfelder, et al.
Ebiomedicine|July 19, 2016
A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to VemurafenibTobias Sinnberg, Elena Makino, Marcel A Krueger, et al.
Immunotherapy|January 5, 2019
Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasisTeresa Amaral, Ioanna Tampouri, Thomas Eigentler, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2024
Isolated melanoma cells in sentinel lymph node in stage IIIA melanoma correlate with a favorable prognosis similar to stage IBTeresa Amaral, Lena Nanz, Rudolf Stadler, et al.
Journal of Cancer Research and Clinical Oncology|February 22, 2022
TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapyJulia Eckardt, Christopher Schroeder, Peter Martus, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 21, 2018
6- and 8-Prenylnaringenin, Novel Natural Histone Deacetylase Inhibitors Found in Hops, Exert Antitumor Activity on Melanoma CellsSascha Venturelli, Heike Niessner, Tobias Sinnberg, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2021
Neoadjuvant and adjuvant end-points in health technology assessment in oncologyNadia Harbeck, Andreas Schneeweiss, Peter Thuss-Patience, et al.
Journal of Innate Immunity|January 25, 2014
Processing of laminin α chains generates peptides involved in wound healing and host defenseIlknur Senyürek, Wolfgang E Kempf, Gerd Klein, et al.
Plos One|August 17, 2019
Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockadeJonas Bochem, Henning Zelba, Teresa Amaral, et al.
Pageof 51